Sotac Pharmaceuticals (NSE:SOTAC) Institutional Ownership: 0.00% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SOTAC Sotac Pharmaceuticals Ltd NSE:SOTAC
49 GF Score
Price ₹91.95
GF Value ₹141.90
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sotac Pharmaceuticals Institutional Ownership?

Sotac Pharmaceuticals NSE:SOTAC 49 Institutional Ownership is 0.00% as of Aug. 15, 2026. GuruFocus rates NSE:SOTAC with a GF Score™ of 49/100 and a GF Value™ of ₹141.90 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sotac Pharmaceuticals's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sotac Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sotac Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Sotac Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sotac Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotac Pharmaceuticals Institutional Ownership Chart

Sotac Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Institutional Ownership
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sotac Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Institutional Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SOTAC
49GF Score
Sotac Pharmaceuticals Ltd NSE:SOTAC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotac Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
Sotac Pharmaceuticals (NSE:SOTAC) has a Institutional Ownership of 0.00% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sotac Pharmaceuticals and its competitors.
Is Sotac Pharmaceuticals' Institutional Ownership too high?
Sotac Pharmaceuticals' current Institutional Ownership is 0.00%. Overall, Sotac Pharmaceuticals has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sotac Pharmaceuticals' Institutional Ownership compare to ZTS?
Sotac Pharmaceuticals' Institutional Ownership of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sotac Pharmaceuticals and its competitors. Sotac Pharmaceuticals's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotac Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sotac Pharmaceuticals (NSE:SOTAC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹141.90, compared to a current price of ₹91.95 — trading 35.2% below its estimated fair value. The current Institutional Ownership is 0.00%. Sotac Pharmaceuticals' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sotac Pharmaceuticals (NSE:SOTAC), the current Institutional Ownership is 0.00% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued. The current stock price of ₹91.95 is trading 35.2% below its estimated GF Value™ of ₹141.90. GuruFocus considers Sotac Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for NSE:SOTAC:

  • Institutional Ownership: 0.00%
  • GF Value™: ₹141.90 vs. price of ₹91.95 (35.2% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotac Pharmaceuticals Business Description

Address Plot No. PF-21 & PF-22/A, Charal Industrial Estate, Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
49GF Score

Get the complete analysis for NSE:SOTAC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹91.95
Price
₹141.90
GF Value